Polymer brushes containing thermosensitive and functional groups grafted onto magnetic nano-particles for interaction and extraction of famotidine in biological samples

被引:9
作者
Panahi, Homayon Ahmad [1 ]
Nasrollahi, Sara [1 ]
机构
[1] Islamic Azad Univ, Cent Tehran Branch, Dept Chem, Tehran, Iran
关键词
Famotidine; Human biological fluids; Solid phase extraction; Enteric drug delivery; Magnetic nano-particles; HUMAN PLASMA; DISEASE; NANOPARTICLES; ADSORPTION; KINETICS;
D O I
10.1016/j.ijpharm.2014.09.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study introduces a new method for grafting poly[N-isopropylacrylamide-co-allyl glycidyl/iminodiacetic] onto iron oxide nano-particles modified using 3-mercaptopropyltrimethoxysilane. The grafted nano-polymer was characterized by Fourier transform infrared spectroscopy, elemental analysis, thermogravimetric analysis, transmission electron microscopy and scanning electron microscopy. The parameters of pH, contact time and temperature of the grafted nano-polymer were investigated. The determination and extraction of famotidine in human biological fluids was evaluated for high accessibility to active sites on the grafted sorbent. The equilibrium adsorption data were analyzed using the Langmuir and Freundlich models. The sorption capacity of the nano-sorbent was 116 mg g(-1) at an optimum pH of 7. About 73% of famotidine was released into simulated gastric fluid by 1 h and 70% was released into simulated intestinal fluids by 30 h at 37 degrees C. These results show that this new magnetic grafted nano-polymer is suitable for enteric drug delivery. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 32 条
  • [1] Boyd B.J., 2008, DRUG DELIV, V5, P69
  • [2] DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS
    BREITNER, JCS
    WELSH, KA
    HELMS, MJ
    GASKELL, PC
    GAU, BA
    ROSES, AD
    PERICAKVANCE, MA
    SAUNDERS, AM
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (04) : 523 - 530
  • [3] Burks T F., 1995, Principles of Pharmacology, P1063
  • [4] DETERMINATION OF FAMOTIDINE IN PLASMA, URINE AND GASTRIC-JUICE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING DISPOSABLE SOLID-PHASE EXTRACTION COLUMNS
    CARLUCCI, G
    BIORDI, L
    NAPOLITANO, T
    BOLOGNA, M
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1988, 6 (05) : 515 - 519
  • [5] Nanomedicine: Developing smarter therapeutic and diagnostic modalities
    Farokhzad, Omid C.
    Langer, Robert
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) : 1456 - 1459
  • [6] Cancer nanotechnology: Opportunities and challenges
    Ferrari, M
    [J]. NATURE REVIEWS CANCER, 2005, 5 (03) : 161 - 171
  • [7] Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
  • [8] PORE- AND SOLID-DIFFUSION KINETICS IN FIXED-BED ADSORPTION UNDER CONSTANT-PATTERN CONDITIONS
    HALL, KR
    EAGLETON, LC
    ACRIVOS, A
    VERMEULEN, T
    [J]. INDUSTRIAL & ENGINEERING CHEMISTRY FUNDAMENTALS, 1966, 5 (02): : 212 - +
  • [9] IMPROVEMENT OF THE INVITRO DISSOLUTION CHARACTERISTICS OF FAMOTIDINE BY INCLUSION IN BETA-CYCLODEXTRIN
    HASSAN, MA
    SULEIMAN, MS
    NAJIB, NM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 58 (01) : 19 - 24
  • [10] Howden CW, 1996, CLIN THER, V18, P36